Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European

Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European

Item

http://www.wikidata.org/entity/Q26749306

Q26749306

about

Lipoprotein apheresis in the management of severe hypercholesterolemia and of elevation of lipoprotein(a): current perspectives and patient selection Accuracy of low-density lipoprotein cholesterol estimation at very low levels.Determination of Fasting and Non-Fasting Cholesterol Levels of Low- and High-Density Lipoproteins with Homogenous Assays: A Promising Reliable Way to Assessment of Dyslipidemia.Alterations in Serum Polyunsaturated Fatty Acids and Eicosanoids in Patients with Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD)A novel approach to screening for familial hypercholesterolemia in a large public venue.Postprandial Hyperlipidemia and Remnant Lipoproteins.Weekday variation in triglyceride concentrations in 1.8 million blood samples.HDL cholesterol: reappraisal of its clinical relevance.Lipid Biomarkers for Risk Assessment in Acute Coronary Syndromes.Dyslipidemia after pediatric renal transplantation-The impact of immunosuppressive regimens.Effects of dyslipidaemia on monocyte production and function in cardiovascular disease.Hypertriglyceridaemia and risk of coronary artery disease.Knowns and unknowns in the care of pediatric familial hypercholesterolemia.ANMCO/ISS/AMD/ANCE/ARCA/FADOI/GICR-IACPR/SICI-GISE/SIBioC/SIC/SICOA/SID/SIF/SIMEU/SIMG/SIMI/SISA Joint Consensus Document on cholesterol and cardiovascular risk: diagnostic-therapeutic pathway in Italy.Plasma concentrations of lipids during pregnancy and the risk of gestational diabetes mellitus: A longitudinal study.Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies.Lipid Profiles, Glycated Hemoglobin, and Diabetes in People Living at High Altitude in Nepal.Positioning about the Flexibility of Fasting for Lipid Profiling.Re-assessing the role of non-fasting lipids; a change in perspective.Comparative Agreement Analysis of Differences in 1,5-Anhydroglucitol, Glycated Albumin, and Glycated Hemoglobin A1c Levels between Fasting and Postprandial States in Steamed Bread Meal Test.Fasting conditions: Influence of water intake on clinical chemistry analytes.Hypertriglyceridemia and atherosclerosis.The influence of dietary and supplemental calcium on postprandial effects of a high-fat meal on lipaemia, glycaemia, C-reactive protein and adiponectin in obese women.The Future of Low-Density Lipoprotein Cholesterol in an Era of Nonfasting Lipid Testing and Potent Low-Density Lipoprotein Lowering.Absolute versus relative measures of plasma fatty acids and health outcomes: example of phospholipid omega-3 and omega-6 fatty acids and all-cause mortality in women.Chylomicronemia risk factors ranked by importance for the individual and community in 108 711 women and men.Unmet need for primary prevention in individuals with hypertriglyceridaemia not eligible for statin therapy according to European Society of Cardiology/European Atherosclerosis Society guidelines: a contemporary population-based study.U-shaped relationship of HDL and risk of infectious disease: two prospective population-based cohort studies.The year in cardiology 2017: prevention.A consensus statement on lipid management after acute coronary syndrome.High density lipoproteins and type 2 inflammatory biomarkers are negatively correlated in atopic asthmatics.Dyslipidaemias: new mechanistic insights and the 2016 ESC Guidelines.Effects of Virgin Olive Oils Differing in Their Bioactive Compound Contents on Metabolic Syndrome and Endothelial Functional Risk Biomarkers in Healthy Adults: A Randomized Double-Blind Controlled Trial.Dyslipidemia among rural and urban HIV patients in south-east Malawi.Relationship between low-density lipoprotein cholesterol and severe acute pancreatitis ("the lipid paradox").Effects of a School-Based Sports Program on Physical Fitness, Physical Activity, and Cardiometabolic Health in Youth With Physical Disabilities: Data From the Sport-2-Stay-Fit Study.Novel method versus the Friedewald method for estimating low-density lipoprotein cholesterol in determination of the eligibility for statin treatment for primary prevention in the United States.Nonfasting Apo-lipoprotein B and Triglyceride levels as a predictor of coronary heart disease in Type II diabetic patients.Postload Glycated Albumin as an Alternate Measure for Diabetes Screening in a Chinese Population.Association of anthropometric measures and cardiovascular risk factors in children and adolescents: Findings from the Aboriginal Birth Cohort study.

P2860

Q28078664-36AAD819-C39C-4A40-86C5-5479E0CA7202 Q33587438-F82B1B27-8A19-4C63-8B67-081C53A5E77B Q33752261-EE5B77B9-3DFA-4A17-8360-B25DAF41D4FC Q37286652-FC7D95B3-EF32-47F7-A4F9-9FCF4283EFBE Q37574714-73075904-3720-4F5B-9C5D-3653F419C543 Q37639159-58522883-B777-4667-BB98-186ED7F0FFB2 Q38734430-6054DFB8-A02B-4347-9C86-A4044B7F0BDA Q38739884-6AEC3ED9-9D91-43BF-923D-4D477AE1CFE1 Q38825512-46010804-F13C-4DA4-9666-43300C8158E2 Q38859167-E330E190-3472-448B-8A5B-ADC0B05EFCDF Q38903993-5FC698A4-3CF0-4519-B3D3-81AFA462ADF5 Q39181612-74990D95-D7F4-4B80-AF24-4D6827EE9DB0 Q39431228-28620AA1-D160-4178-92E9-502896E5E9DA Q40104818-31BF9D56-DC21-4A14-A0F6-7FA3B93CF49D Q40230665-E7D31DCE-1C66-4CC4-A9A4-6C37EC206DEE Q40238320-03D9DDC5-99E1-4C7B-AD49-4A2D6191C800 Q41659678-FE999B93-10AB-42DA-8C09-65B33CB06809 Q42291780-6B9D4AE7-69DE-45E3-883A-5BD88C520791 Q42363122-3FCAF4C6-68A7-421A-86FC-A0D407797F5D Q47115413-79820B0B-2521-4399-956C-C50798CAD666 Q47126780-2CDDA67A-2511-4867-A913-8D83992BF112 Q47180199-8EF2EBC8-5C8D-4722-95F5-7E91BC3D53FE Q47620268-7DF4E4E0-92FC-4201-8C8A-345B80D71B95 Q47763090-2412DD1E-DABF-48A1-BA59-6F95415BB7D3 Q48136448-EB7D3F79-E65D-4367-A282-CD4C683145F8 Q48318089-3BE49F80-6D77-4EEA-BD7C-8FDDC4FF3F1D Q49574252-060E90F6-2F77-410D-9528-AA5DEE73AC3C Q49937955-0EE346B7-A627-4597-858A-9891A64E1F64 Q50193445-9BEB828E-2EDE-416E-8C12-854A49CCA2BA Q50547169-AD4B5EDA-584A-46C9-9A52-E3B980699186 Q50558071-4ACD34F9-A28B-4173-B965-6A4C9BC9F2B1 Q53644756-75EED805-2A8D-46EC-946E-C6CE7E1D3936 Q53818426-CDD0D310-FDE2-48C9-AFAB-9F0CC5FB92E7 Q54204331-06CC75A6-3795-4DBF-8130-90758AA6ED63 Q55041188-2B0D0693-39C9-4063-8BCC-01626F066ED7 Q55072078-9B1ADCA1-797C-4B08-87B7-6FAB987FF259 Q55111553-FD541844-C286-476C-89D6-9689AC069D88 Q55315345-FD0B257C-9622-4E66-A6E1-70D0620E9357 Q55359935-0E1EE533-9683-4BEB-AFA5-106A33E0979D Q55428280-91C46F2D-0E60-40DD-8425-A48525B14CFD

P2860

Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European

Item

http://www.wikidata.org/entity/Q26749306

description

2016 nî lūn-bûn

@nan

2016 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Fasting is not routinely requi ...... sclerosis Society and European

@nl

type

Item

label

Fasting is not routinely requi ...... sclerosis Society and European

@nl

prefLabel

Fasting is not routinely requi ...... sclerosis Society and European

@nl

P1476

Fasting is not routinely requi ...... mistry and Laboratory Medicine

@en

P2093

Alan T Remaley

http://www.w3.org/2001/XMLSchema#string

Anne Langsted

http://www.w3.org/2001/XMLSchema#string

Christa Cobbaert

http://www.w3.org/2001/XMLSchema#string

Eric Bruckert

http://www.w3.org/2001/XMLSchema#string

Genovefa Kolovou

http://www.w3.org/2001/XMLSchema#string

Gerald F Watts

http://www.w3.org/2001/XMLSchema#string

Grazyna Sypniewska

http://www.w3.org/2001/XMLSchema#string

Hannsjörg Baum

http://www.w3.org/2001/XMLSchema#string

Kari Pulkki

http://www.w3.org/2001/XMLSchema#string

M John Chapman

http://www.w3.org/2001/XMLSchema#string

P2860

Lipoprotein(a) as a cardiovascular risk factor: current status

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society

Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association

Evaluation of methods for the measurement of low-density lipoprotein cholesterol.

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society.

Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management

ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

Fasting time and lipid levels in a community-based population: a cross-sectional study.

Remnant cholesterol as a causal risk factor for ischemic heart disease.

P304

1944-58

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2079819

http://www.w3.org/2001/XMLSchema#string

P356

10.1093/EURHEARTJ/EHW152

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Florian Kronenberg

Emilio Ros

Arnold von Eckardstein

Jan Borén

Børge G. Nordestgaard

Olov Wiklund

Nader Rifai

P577

2016-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27122601

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

4929379

http://www.w3.org/2001/XMLSchema#string

Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European

about

P2860

P2860

Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P3181

P356

P407

P433

P478

P50

P577

P698

P921

P932

P3181

P356

P1433

P1476

P2093

P2860

P304

P31

P3181

P356

P407

P433

P478

P50

P577

P698

P921

P932